These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

729 related items for PubMed ID: 24387981

  • 1. Synthesis and evaluation of novel benzimidazole derivatives as sirtuin inhibitors with antitumor activities.
    Yoon YK, Ali MA, Wei AC, Choon TS, Osman H, Parang K, Shirazi AN.
    Bioorg Med Chem; 2014 Jan 15; 22(2):703-10. PubMed ID: 24387981
    [Abstract] [Full Text] [Related]

  • 2. Benzimidazoles as new scaffold of sirtuin inhibitors: green synthesis, in vitro studies, molecular docking analysis and evaluation of their anti-cancer properties.
    Yoon YK, Ali MA, Wei AC, Shirazi AN, Parang K, Choon TS.
    Eur J Med Chem; 2014 Aug 18; 83():448-54. PubMed ID: 24992072
    [Abstract] [Full Text] [Related]

  • 3. Thieno[2,3-d]pyrimidin-4(3H)-one Derivatives of Benzimidazole as Potential Anti- Breast Cancer (MDA-MB-231, MCF-7) Agents.
    Dimov S, Mavrova AT, Yancheva D, Nikolova B, Tsoneva I.
    Anticancer Agents Med Chem; 2021 Aug 18; 21(11):1441-1450. PubMed ID: 32698751
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Synthesis, antitumor activity and SAR study of novel [1,2,4]triazino[4,5-a]benzimidazole derivatives.
    El-Nassan HB.
    Eur J Med Chem; 2012 Jul 18; 53():22-7. PubMed ID: 22542105
    [Abstract] [Full Text] [Related]

  • 7. Synthesis of certain benzothieno[3,2-d]pyrimidine derivatives as a selective SIRT2 inhibitors.
    Khalil NA, Ahmed EM, Zaher AF, El-Zoghbi MS, Sobh EA.
    Eur J Med Chem; 2020 Feb 01; 187():111926. PubMed ID: 31812033
    [Abstract] [Full Text] [Related]

  • 8. Microwave-assisted synthesis of sec/tert-butyl 2-arylbenzimidazoles and their unexpected antiproliferative activity towards ER negative breast cancer cells.
    Abdul Rahim AS, Salhimi SM, Arumugam N, Pin LC, Yee NS, Muttiah NN, Keat WB, Abd Hamid S, Osman H, Mat Ib.
    J Enzyme Inhib Med Chem; 2013 Dec 01; 28(6):1255-60. PubMed ID: 23061895
    [Abstract] [Full Text] [Related]

  • 9. Design, synthesis and structure-activity relationship studies of novel sirtuin 2 (SIRT2) inhibitors with a benzamide skeleton.
    Sakai T, Matsumoto Y, Ishikawa M, Sugita K, Hashimoto Y, Wakai N, Kitao A, Morishita E, Toyoshima C, Hayashi T, Akiyama T.
    Bioorg Med Chem; 2015 Jan 15; 23(2):328-39. PubMed ID: 25515955
    [Abstract] [Full Text] [Related]

  • 10. Design, synthesis and biological evaluation of novel hybrid compounds of imidazole scaffold-based 2-benzylbenzofuran as potent anticancer agents.
    Wang XQ, Liu LX, Li Y, Sun CJ, Chen W, Li L, Zhang HB, Yang XD.
    Eur J Med Chem; 2013 Apr 15; 62():111-21. PubMed ID: 23353748
    [Abstract] [Full Text] [Related]

  • 11. Design, synthesis, molecular docking and cytotoxic evaluation of novel 2-furybenzimidazoles as VEGFR-2 inhibitors.
    Abdullaziz MA, Abdel-Mohsen HT, El Kerdawy AM, Ragab FAF, Ali MM, Abu-Bakr SM, Girgis AS, El Diwani HI.
    Eur J Med Chem; 2017 Aug 18; 136():315-329. PubMed ID: 28505536
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Synthesis and docking studies of novel antitumor benzimidazoles.
    Omar MA, Shaker YM, Galal SA, Ali MM, Kerwin SM, Li J, Tokuda H, Ramadan RA, El Diwani HI.
    Bioorg Med Chem; 2012 Dec 15; 20(24):6989-7001. PubMed ID: 23123017
    [Abstract] [Full Text] [Related]

  • 14. Discovery of N-(2-phenyl-1H-benzo[d]imidazol-5-yl)quinolin-4-amine derivatives as novel VEGFR-2 kinase inhibitors.
    Shi L, Wu TT, Wang Z, Xue JY, Xu YG.
    Eur J Med Chem; 2014 Sep 12; 84():698-707. PubMed ID: 25064347
    [Abstract] [Full Text] [Related]

  • 15. Synthesis and biological activity of novel inhibitors of topoisomerase I: 2-aryl-substituted 2-bis-1H-benzimidazoles.
    Singh M, Tandon V.
    Eur J Med Chem; 2011 Feb 12; 46(2):659-69. PubMed ID: 21186067
    [Abstract] [Full Text] [Related]

  • 16. Synthesis of new conjugated coumarin-benzimidazole hybrids and their anticancer activity.
    Paul K, Bindal S, Luxami V.
    Bioorg Med Chem Lett; 2013 Jun 15; 23(12):3667-72. PubMed ID: 23642480
    [Abstract] [Full Text] [Related]

  • 17. Design, synthesis and biological evaluation of 1,3-diphenyl-1H-pyrazole derivatives containing benzimidazole skeleton as potential anticancer and apoptosis inducing agents.
    Reddy TS, Kulhari H, Reddy VG, Bansal V, Kamal A, Shukla R.
    Eur J Med Chem; 2015 Aug 28; 101():790-805. PubMed ID: 26231080
    [Abstract] [Full Text] [Related]

  • 18. Design, synthesis and biological evaluation of novel benzimidazole-2-substituted phenyl or pyridine propyl ketene derivatives as antitumour agents.
    Wu LT, Jiang Z, Shen JJ, Yi H, Zhan YC, Sha MQ, Wang Z, Xue ST, Li ZR.
    Eur J Med Chem; 2016 May 23; 114():328-36. PubMed ID: 27017265
    [Abstract] [Full Text] [Related]

  • 19. Synthesis of novel benzimidazole functionalized chiral thioureas and evaluation of their antibacterial and anticancer activities.
    Madabhushi S, Mallu KK, Vangipuram VS, Kurva S, Poornachandra Y, Ganesh Kumar C.
    Bioorg Med Chem Lett; 2014 Oct 15; 24(20):4822-5. PubMed ID: 25241926
    [Abstract] [Full Text] [Related]

  • 20. Synthesis and cytotoxic evaluation of novel 2-(4-(2,2,2-trifluoroethoxy)-3-methylpyridin-2-ylthio)-1H-benzo[d]imidazole derivatives.
    Ranganatha SR, Kavitha CV, Vinaya K, Prasanna DS, Chandrappa S, Raghavan SC, Rangappa KS.
    Arch Pharm Res; 2009 Oct 15; 32(10):1335-43. PubMed ID: 19898794
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 37.